These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33915734)

  • 21. miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer's disease.
    Zheng K; Hu F; Zhou Y; Zhang J; Zheng J; Lai C; Xiong W; Cui K; Hu YZ; Han ZT; Zhang HH; Chen JG; Man HY; Liu D; Lu Y; Zhu LQ
    Nat Commun; 2021 Mar; 12(1):1903. PubMed ID: 33771994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.
    Hu YK; Wang X; Li L; Du YH; Ye HT; Li CY
    Neurosci Bull; 2013 Dec; 29(6):745-51. PubMed ID: 23740209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
    He B; Chen W; Zeng J; Tong W; Zheng P
    J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor.
    Zhang J; Liu Z; Pei Y; Yang W; Xie C; Long S
    Neurochem Res; 2018 Mar; 43(3):736-744. PubMed ID: 29464486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofibrillary tangles and tau phosphorylation.
    Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G
    Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease.
    Chen D; Lan G; Li R; Mei Y; Shui X; Gu X; Wang L; Zhang T; Gan CL; Xia Y; Hu L; Tian Y; Zhang M; Lee TH
    Transl Neurodegener; 2022 May; 11(1):27. PubMed ID: 35527277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
    Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
    J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.
    Pei JJ; Braak H; An WL; Winblad B; Cowburn RF; Iqbal K; Grundke-Iqbal I
    Brain Res Mol Brain Res; 2002 Dec; 109(1-2):45-55. PubMed ID: 12531514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-Abl tyrosine kinase signaling: a new player in AD tau pathology.
    Estrada LD; Zanlungo SM; Alvarez AR
    Curr Alzheimer Res; 2011 Sep; 8(6):643-51. PubMed ID: 21605041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain.
    Salta E; Sierksma A; Vanden Eynden E; De Strooper B
    EMBO Mol Med; 2016 Sep; 8(9):1005-18. PubMed ID: 27485122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM; Vandré DD
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease.
    Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD
    Sci Rep; 2016 May; 6():26697. PubMed ID: 27221467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neurotoxic Role of Extracellular Tau Protein.
    Sebastián-Serrano Á; de Diego-García L; Díaz-Hernández M
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.